Biotech · Private company
LumiThera, Inc.
Track this companyFree. Adds LumiThera, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Valeda Light Delivery SystemPhase 3 · Dry Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- PhotobiomodulationAge Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Valeda Light Delivery System Sham ModeDry Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)PHASE2_PHASE3 · UNKNOWN · started Oct 25, 2023ClinicalTrials.gov NCT06229665 · fetched Nov 12, 2026
- A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)RECRUITING · started Sep 1, 2023ClinicalTrials.gov NCT06351605 · fetched Nov 12, 2026
- Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular DegenerationNA · COMPLETED · started Aug 20, 2020ClinicalTrials.gov NCT04522999 · fetched Nov 12, 2026
- Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)NA · COMPLETED · started Sep 23, 2019ClinicalTrials.gov NCT04065490 · fetched Nov 12, 2026